Cargando…

Treatment of bleeding in patients with liver disease

Patients with cirrhosis frequently have complex alterations in their hemostatic system. Although routine diagnostic tests of hemostasis in cirrhosis (platelet count, prothrombin time, fibrinogen level) are suggestive of a bleeding tendency, it is now widely accepted that these tests do not reflect h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Northup, Patrick G., Lisman, Ton, Roberts, Lara N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Jth in Clinic
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362012/ https://www.ncbi.nlm.nih.gov/pubmed/33974330 http://dx.doi.org/10.1111/jth.15364

Ejemplares similares

Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome—What is the evidence?
por: Hamulyák, Eva N., et al.
Publicado: (2021)

The myths behind DOAC measurement: Analyses of prescribing information from different regulatory bodies and a call for harmonization
por: Gosselin, Robert C., et al.
Publicado: (2022)

F5‐Atlanta: Factor V‐short strikes again
por: Castoldi, Elisabetta
Publicado: (2021)

Publishing for science or science for publications? The role of open science to reduce research waste
por: Siegerink, Bob, et al.
Publicado: (2021)

iPSC diversity: A key for better use and improved targeting
por: Abbonante, Vittorio, et al.
Publicado: (2021)

Antibody‐mediated platelet activation in COVID‐19: A coincidence or a new mechanism of the dysregulated coagulation system?
por: Althaus, Karina, et al.
Publicado: (2021)

Commentary on “The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1”
por: von Meijenfeldt, Fien A.
Publicado: (2022)

Trauma is an exhausting platelet experience
por: Holinstat, Michael
Publicado: (2022)

Commentary on “Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism”: A new role for plasminogen activator inhibitor‐1—An inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity
por: Wojta, Johann
Publicado: (2022)

Another piece of knowledge in the puzzle of procoagulant COAT platelets
por: Aliotta, Alessandro, et al.
Publicado: (2022)

Von Willebrand factor and cancer: Another piece of the puzzle
por: Denis, Cécile V., et al.
Publicado: (2022)

Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases
por: Lisman, Ton, et al.
Publicado: (2017)

Pathophysiology and management of bleeding and thrombosis in patients with liver disease
por: van den Boom, Bente P., et al.
Publicado: (2022)

Bleeding and Thrombosis in Patients With Cirrhosis: What’s New?
por: Lisman, Ton
Publicado: (2023)

The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease
por: Lisman, Ton, et al.
Publicado: (2021)

Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease
por: von Meijenfeldt, Fien A., et al.
Publicado: (2020)

The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease
por: Scheiner, Bernhard, et al.
Publicado: (2020)

VWF/ADAMTS13 Imbalance, But Not Global Coagulation or Fibrinolysis, Is Associated With Outcome and Bleeding in Acute Liver Failure
por: Driever, Ellen G., et al.
Publicado: (2021)

Perioperative antithrombotic therapy does not increase the incidence of early postoperative thromboembolic complications and bleeding in kidney transplantation – a retrospective study
por: van den Berg, Tamar A. J., et al.
Publicado: (2019)

Platelet–neutrophil interactions as drivers of inflammatory and thrombotic disease
por: Lisman, Ton
Publicado: (2017)

Unravelling the Role of Neutrophil Extracellular Traps in Acute Liver Failure
por: von Meijenfeldt, Fien A., et al.
Publicado: (2022)

Global hemostatic status in patients with acute‐on‐chronic liver failure and septics without underlying liver disease
por: Lisman, Ton, et al.
Publicado: (2020)

Heparins have adequate ex vivo anticoagulant effects in hospitalized patients with cirrhosis
por: van den Boom, Bente P., et al.
Publicado: (2021)

Spontaneous intercostal artery bleeding in a patient with alcohol‐induced liver cirrhosis
por: Rahi, Mandeep Singh, et al.
Publicado: (2021)

Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis
por: Lisman, Ton, et al.
Publicado: (2023)

Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice
por: Karimian, Golnar, et al.
Publicado: (2015)

Determining Risk Factors of Bleeding in Patients on Warfarin Treatment
por: Uygungül, Evren, et al.
Publicado: (2014)

Plasma From Patients Undergoing Liver Transplantation Is Resistant to Anticoagulant Activity of Soluble Thrombomodulin
por: Burlage, Laura C., et al.
Publicado: (2019)

Risk Factors Associated with Reoperation for Bleeding following Liver Transplantation
por: Thompson, Maxwell A., et al.
Publicado: (2014)

Fibrin clot properties and thrombus composition in cirrhosis
por: Driever, Ellen G., et al.
Publicado: (2023)

Early elevated serum gamma glutamyl transpeptidase after liver transplantation is associated with better survival
por: Alkozai, Edris M, et al.
Publicado: (2014)

Baseline Renal Function Predicts Hyponatremia in Liver Cirrhosis Patients Treated with Terlipressin for Variceal Bleeding
por: Kim, Sung Eun, et al.
Publicado: (2017)

Differentiating biochemical from clinical heparin resistance in COVID-19
por: Lisman, Ton, et al.
Publicado: (2020)

Tranexamic Acid Is Not a Universal Hemostatic Agent
por: Schutgens, Roger E. G., et al.
Publicado: (2021)

Evidence against a role for platelet-derived molecules in liver regeneration after partial hepatectomy in humans
por: Kirschbaum, Marc, et al.
Publicado: (2016)

Effect of High-Dose Oral Rabeprazole on Recurrent Bleeding after Endoscopic Treatment of Bleeding Peptic Ulcers
por: Kim, Hyung-Keun, et al.
Publicado: (2012)

Sustained prothrombotic changes in convalescent patients with COVID-19
por: von Meijenfeldt, Fien A, et al.
Publicado: (2021)

Safety of direct oral anticoagulants in patients with advanced liver disease
por: Semmler, Georg, et al.
Publicado: (2021)

Diffuse reflectance spectroscopy accurately quantifies various degrees of liver steatosis in murine models of fatty liver disease
por: Westerkamp, Andrie C., et al.
Publicado: (2015)

Hemostasis, bleeding and thrombosis in liver disease
por: Flores, Brisas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e3h9jcr30l4qs7gki9ravq15rp